|
| 36124697 | Impact of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Vaccination and Booster on Coronavirus Disease 2019 (COVID-19) Symptom Severity Over Time in the COVID-OUT Trial. | Clin Infect Dis | 2023 |
| 37985892 | Development of a proteomic signature associated with severe disease for patients with COVID-19 using data from 5 multicenter, randomized, controlled, and prospective studies. | Sci Rep | 2023 |
| 38033705 | Strategies used for the COVID-OUT decentralized trial of outpatient treatment of SARS-CoV-2. | J Clin Transl Sci | 2023 |
| 37125061 | Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? A population-level view in the EHR-based RECOVER program. | J Clin Transl Sci | 2023 |
| 37284921 | Does COVID-19 Infection Increase the Risk of Diabetes? Current Evidence. | Curr Diab Rep | 2023 |
| 37339345 | Metformin for Treatment of Acute COVID-19: Systematic Review of Clinical Trial Data Against SARS-CoV-2. | Diabetes Care | 2023 |
| 37302406 | Outpatient treatment of COVID-19 and incidence of post-COVID-19 condition over 10 months (COVID-OUT): a multicentre, randomised, quadruple-blind, parallel-group, phase 3 trial. | Lancet Infect Dis | 2023 |
| 37333243 | Metformin reduces SARS-CoV-2 in a Phase 3 Randomized Placebo Controlled Clinical Trial. | medRxiv | 2023 |
| 37264767 | Evaluating potential predictors of weight loss response to liraglutide in adolescents with obesity: A post hoc analysis of the randomized, placebo-controlled SCALE Teens trial. | Pediatr Obes | 2023 |
| 36633838 | Effect of Fluvoxamine vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. | JAMA | 2023 |
| 34718333 | BMI metrics and their association with adiposity, cardiometabolic risk factors, and biomarkers in children and adolescents. | Int J Obes (Lond) | 2022 |
| 35432917 | Anti-obesity medication prescriptions by race/ethnicity and use of an interpreter in a pediatric weight management clinic. | Ther Adv Endocrinol Metab | 2022 |
| 35533387 | Care of the Patient After Metabolic and Bariatric Surgery. | Ann Intern Med | 2022 |
| 35392460 | Vaccination Against SARS-CoV-2 Is Associated With a Lower Viral Load and Likelihood of Systemic Symptoms. | Open Forum Infect Dis | 2022 |
| 36400170 | Metformin is associated with reduced COVID-19 severity in patients with prediabetes. | Diabetes Res Clin Pract | 2022 |
| 36597543 | Outpatient treatment of Covid-19 with metformin, ivermectin, and fluvoxamine and the development of Long Covid over 10-month follow-up. | medRxiv | 2022 |
| 36482974 | Are fewer cases of diabetes mellitus diagnosed in the months after SARS-CoV-2 infection? | medRxiv | 2022 |
| 36070710 | Randomized Trial of Metformin, Ivermectin, and Fluvoxamine for Covid-19. | N Engl J Med | 2022 |
| 36269852 | Effect of Ivermectin vs Placebo on Time to Sustained Recovery in Outpatients With Mild to Moderate COVID-19: A Randomized Clinical Trial. | JAMA | 2022 |
| 36098660 | Effect of SARS-CoV-2 Infection and Infection Severity on Longer-Term Glycemic Control and Weight in People With Type 2 Diabetes. | Diabetes Care | 2022 |
| 36299427 | Fluvoxamine for Outpatient Treatment of COVID-19: A Decentralized, Placebo-controlled, Randomized, Platform Clinical Trial. | medRxiv | 2022 |
| 36093353 | Metformin is Associated with Reduced COVID-19 Severity in Patients with Prediabetes. | medRxiv | 2022 |
| 36395143 | Diabetes medications and associations with Covid-19 outcomes in the N3C database: A national retrospective cohort study. | PLoS One | 2022 |
| 35202458 | Glycemic Control and Clinical Outcomes in U.S. Patients With COVID-19: Data From the National COVID Cohort Collaborative (N3C) Database. | Diabetes Care | 2022 |
| 33314219 | mTOR inhibition in COVID-19: A commentary and review of efficacy in RNA viruses. | J Med Virol | 2021 |
| 33521772 | Metformin and risk of mortality in patients hospitalised with COVID-19: a retrospective cohort analysis. | Lancet Healthy Longev | 2021 |
| 33791733 | Challenges in defining Long COVID: Striking differences across literature, Electronic Health Records, and patient-reported information. | medRxiv | 2021 |
| 33648370 | We Should Do More to Offer Evidence-Based Treatment for an Important Modifiable Risk Factor for COVID-19: Obesity. | J Prim Care Community Health | 2021 |
| 33580540 | Outpatient metformin use is associated with reduced severity of COVID-19 disease in adults with overweight or obesity. | J Med Virol | 2021 |
| 34042604 | Patient Recruitment Into a Multicenter Clinical Cohort Linking Electronic Health Records From 5 Health Systems: Cross-sectional Analysis. | J Med Internet Res | 2021 |
| 34326020 | Metabolic surgery may protect against admission for COVID-19 in persons with nonalcoholic fatty liver disease. | Surg Obes Relat Dis | 2021 |
| 34297343 | The Most Undertreated Chronic Disease: Addressing Obesity in Primary Care Settings. | Curr Obes Rep | 2021 |
| 34061621 | Contribution of Hedonic Hunger and Binge Eating to Childhood Obesity. | Child Obes | 2021 |
| 34367059 | Metformin and Covid-19: Focused Review of Mechanisms and Current Literature Suggesting Benefit. | Front Endocrinol (Lausanne) | 2021 |
| 34191405 | Affordability and features of home scales for self-weighing. | Clin Obes | 2021 |
| 32383356 | Minority and low-income patients are less likely to have a scale for self-weighing in their home: A survey in primary care. | Clin Obes | 2020 |
| 32010059 | Cardiovascular Risks and Benefits of Medications Used for Weight Loss. | Front Endocrinol (Lausanne) | 2020 |
| 33082992 | Associations between paediatric fatigue and eating behaviours. | Obes Sci Pract | 2020 |
| 33082991 | Parents lose less weight than nonparents in an intensive lifestyle intervention. | Obes Sci Pract | 2020 |
| 32607520 | Observational Study of Metformin and Risk of Mortality in Patients Hospitalized with Covid-19. | medRxiv | 2020 |
| 32909011 | Non-alcoholic fatty liver disease (NAFLD) and risk of hospitalization for Covid-19. | medRxiv | 2020 |
| 32446748 | Provider Advice and Patient Perceptions on Weight Across Five Health Systems. | Am J Prev Med | 2020 |
| 30640387 | Fish Consumption During Pregnancy-Reply. | JAMA Pediatr | 2019 |
| 31384417 | Precision medicine in adult and pediatric obesity: a clinical perspective. | Ther Adv Endocrinol Metab | 2019 |
| 31515965 | Geographic Availability of Physicians Certified by the American Board of Obesity Medicine Relative to Obesity Prevalence. | Obesity (Silver Spring) | 2019 |
| 31313111 | Understanding Primary Care Patients' Self-weighing Habits: Cohort Analysis from the PaTH Clinical Data Research Network. | J Gen Intern Med | 2019 |
| 31054014 | Severe Obesity in the Pediatric Population: Current Concepts in Clinical Care. | Curr Obes Rep | 2019 |
| 30573143 | Systematic Review of Natural Experiments for Childhood Obesity Prevention and Control. | Am J Prev Med | 2019 |
| 29733047 | Worksite physical activity breaks: Perspectives on feasibility of implementation. | Work | 2018 |
| 30039174 | Fish Consumption During Pregnancy: An Opportunity, Not a Risk. | JAMA Pediatr | 2018 |